Pivotal Role of Superoxide Anion and Beneficial Effect of Antioxidant Molecules in Murine Steatohepatitis

Hepatology

Volumn 39, Issue 5, 2004, Pages 1277-1285

  Laurent, Alexis ^a   Nicco, Carole ^b   Van Nhieu, Jeanne Tran ^c   Borderie, Didier ^a   Chéreau, Christiane ^a   Conti, Filomena ^b   Jaffray, Patrick ^a   Soubrane, Olivier ^b   Calmus, Yvon ^b   Weill, Bernard ^a   Batteux, Frédéric ^a  

^a Hôpital Cochin ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ANTIOXIDANT; BENZOIC ACID DERIVATIVE; COPPER DIISOPROPYL SALICYLATE; LEPTIN; MANGANESE TETRAKIS(5,10,15,20 BENZOIC ACID); REACTIVE OXYGEN METABOLITE; SALICYLIC ACID; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; MOLECULAR MIMICRY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEATOHEPATITIS; STEATOSIS;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY WEIGHT; CASPASE 3; CASPASES; CYTOCHROMES C; FATTY LIVER; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MITOCHONDRIA, LIVER; NITRIC OXIDE; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 2342591361     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20177     Document Type: Article

References (43)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999;19:221-229.
3. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002;282:G193-G199.
4. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-176.
5. Chitturi S, Farrell GC. Edopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27-41.
6. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-293.
7. Brady LJ, Brady PS, Romsos DR, Hoppel CL. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice. Biochem J 1985;231:439-444.
8. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845.
9. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997;272:20313-20316.
10. Fridovich I. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J Biol Chem 1997;272:18515-18517.
11. Henle ES, Linn S. Formation, prevention, and repair ofDNA damage by iron/hydrogen peroxide. J Biol Chem 1997;272:19095-19098.
12. Koteish A, Diehl AM, Animal models of steatosis. Semin Liver Dis 2001;21:89-104.
13. Patel M, Day BJ. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci 1999;20:359-364.
14. Leuthauser SW, Oberley LW, Oberley TD, Sorenson JR, Ramakrishna K. Antitumor effect of a copper coordination compound with superoxide dismutase-like activity. J Natl Cancer Inst 1981;66:1077-1081.
15. Gillissen A, Scharling B, Jaworska M, Barding A, Rasche K, SchultzeWerninghaus G. Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine. Res Exp Med 1997;196:389-398.
16. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bd-2; release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132.
17. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-287.
18. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-126.
19. Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990;190:360-365.
20. Massy ZA, Borderie D, Nguyen-Khoa T, Drueke TB, Ekindjian OG, Lacour B. Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol Dial Transplant 2003;18:153-157.
21. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, et al. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1997;1:177-189.
22. Le Goffe C, Vallette G, Jarry A, Bou-Hanna C, Laboisse CL. The in vitro manipulation of carbohydrate metabolism: a new strategy for deciphering the cellular defence mechanisms against nitric oxide attack. Biochem J 1999;344 Pt 3:643-648.
23. Nakao C, Ookawara T, Sato Y, Kizaki T, Imazeki N, Matsubara O, et al. Extracellular superoxide dismutase in tissues from obese (ob/ob) mice. Free Radic Res 2000;33:229-241.
24. Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol 2001;281:G382-G392.
25. Welsh JJ, Narbaitz R, Begin-Heick N. Metabolic effects of dietary manganese supplementation in ob/ob mice. J Nutr 1985;115:919-928.
26. Ozata M, Uckaya G, Aydin A, Isimer A, Ozdemir IC. Defective andoxidant defense system in patients with a human leptin gene mutation. Horm Merab Res 2000;32:269-272.
27. Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leprin treatment in ob/ob mouse liver. J Biol Chem 2001;276:49066-49076.
28. Prohaska JR, Wittmers LE Jr, Haller EW. Influence of genetic obesity, food intake and adrenalectomy in mice on selected trace element-dependent protective enzymes. J Nutr 1988;118:739-746.
29. Malassagne B, Ferrer PJ, Hammoud R, Tulliez M, Bedda S, Trebeden H, et al. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology 2001;121:1451-1459.
30. Ferret PJ, Hammoud R, Tulliez, M, Tran A, Trebeden H, Jaffray P, et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. HEPATOLOGY 2001;33:1173-1180.
31. Jourd'heuil D, Jourd'heuil FL, Kutchukian PS, Musah RA, Wink DA, Grisham MB. Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem 2001;276:28799-28805.
32. Kumar VB, Bernardo AE, Vyas K, Franko M, Farr S, Lakshmanan L, et al. Effect of metformin on nitric oxide synthase in genetically obese (ob/ob) mice. Life Sci 2001;69:2789-2799.
33. Morley JE, Kumar VB, Mattammal M, Villareal DT. Measurement of nitric oxide synthase and its mRNA in genetically obese (ob/ob) mice. Life Sci 1995;57:1327-1331.
34. Borderie D, Hernvann A, Hilliquin P, Lemarchal H, Kahan A, Ekindjian OG. Tetracyclines inhibit nitrosothiol production by cytokine-stimalated osteoarthritic synovial cells. Inflamm Res 2001;50:409-414.
35. Jourd'heuil D, Jourd'heuil FL, Feelisch M. Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanism. J Biol Chem 2003;20:20.
36. Landino LM, Crews BC, Timmons MD, Morrow JD, Mamett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A 1996;93:15069-15074.
37. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
38. Capel ID, Dorrell HM. Abnormal antioxidant defence in some tissues of congenitally obese mice. Biochem J 1984;219:41- 49.
39. Watson AM, Poloyac SM, Howard G, Blouin RA. Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse. Drug Metab Dispos 1999;27:695-700.
40. Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997;38:205-227.
41. Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetarninophen poisoning: a critical review. J Toxicol Clin Toxicol 1998;36:277-285.
42. Robertson G, Ledercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physio12001;281:G1135-G1139
43. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. HEPATOLOGY 2003;37:343-350.